Exxon raises US$9.5 billion to load up on cash while debt market still open to new deals

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 66%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Exxon Mobil Corp on Monday raised US$9.5 billion in new debt, with the largest U.S. oil producer seeking to bolster its finances while debt ...

Exxon Mobil Corp on Monday raised US$9.5 billion in new debt, with the largest U.S. oil producer seeking to bolster its finances while debt markets remain open to new deals.

Exxon paid a lower price to borrow than it did in a similar debt deal almost four weeks ago, a sign of how investor confidence is gradually returning after a rout in energy prices and a stock market collapse fueled by the coronavirus outbreak.Nevertheless, borrowing costs for Exxon were still higher than prior to the coronavirus outbreak.

In an example of how the company's borrowing costs have come down in recent weeks, it priced a 10.5-year bond worth US$2 billion at a 185 basis-point premium to U.S. Treasuries with a 2.61per cent yield. On March 17, Exxon sold US$2 billion in debt with a 10-year duration where the premium to U.S. Treasuries was 240 basis points and the yield was 3.482per cent.

The logic behind Exxon's deal was to stock up further on cash while the market is still open to issuers of new debt, according to a person familiar with the matter.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GE cuts some debt using proceeds from sale of biopharma businessGeneral Electric Co said on Monday it used part of the US$20 billion in proceeds from the sale of its biopharma business to cut debt.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »